Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Horm Behav. 2021 Mar 11;130:104964. doi: 10.1016/j.yhbeh.2021.104964

Table 1:

Linear models testing effects of treatment and other covariates on male hormone levels. Estimates use saline as the reference for treatment and Y1 as reference for year. Pre-injection T and ΔT values were log-transformed. Inclusion and exclusion of covariates determined via systematic comparison of candidate models (supplemental tables 24). Signficant predictors are bolded (p<0.05). Letters denote separate models.

Response variable Predictor variable Estimate (± SE) F-statistic p-value
ΔTestosterone (post minus pre-injection)
(a) Treatment 1.37 ± 0.50 F1,65= 20.9 p<0.0001
Date 0.0020 ± 0.0026 F1,65= 3.24 p=0.077
Treatment*Date −0.0077 ± 0.0034 F1,65= 5.19 p=0.026
Mass 0.029 ± 0.016 F165= 4.05 p=0.049

Pre-injection Testosterone
(b) Treatment −0.247 ± 0.20 F1,65= 1.27 p=0.26
Date −0.017 ± 0.011 F1,65=5.62 p=0.021
Year 0.49 ± 0.24 (Y2) F2,65=3.08 p=0.053
−0.50 ± 0.26 (Y3)

Post-injection Corticosterone
(c) Treatment 6.11 ± 9.62 F1,33=0.40 p=0.53